FDA Investigating CAR-T Cancer Therapy Safety Risks

Published on November 28, 2023

The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies made by companies such as Gilead Sciences and Johnson & Johnson over the risk of hospitalizations and death due to a serious safety issue. The FDA said it had received reports…

Read Full Article (External Site)